Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 34, Issue 3, Pages 240-250
Publisher
Wiley
Online
2013-08-08
DOI
10.1002/phar.1337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Activity of Tedizolid Phosphate (TR-701) in Murine Models of Infection with Penicillin-Resistant and Penicillin-Sensitive Streptococcus pneumoniae
- (2012) Sunghak Choi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
- (2012) Philippe Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers
- (2012) Seth T. Housman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Efficacies of Human Simulated Exposures of Tedizolid and Linezolid against Staphylococcus aureus in the Murine Thigh Infection Model
- (2012) R. A. Keel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VivoEfficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model
- (2012) Pamela R. Tessier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)
- (2012) Robert K. Flamm et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers
- (2012) Martina Sahre et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In VivoPharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
- (2011) Weon Bin Im et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections
- (2010) P. Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance
- (2010) Stefania Stefani et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent
- (2009) R. Schaadt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trends in the Incidence of Methicillin‐ResistantStaphylococcus aureusInfection in Children’s Hospitals in the United States
- (2009) Jeffrey S. Gerber et al. CLINICAL INFECTIOUS DISEASES
- Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
- (2009) H. M. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started